LONDON, July 1, 2026, 16:02 (BST)
- RELX was up 0.38% at 2,375p as of 16:02 BST on the London Stock Exchange. The regular session ran from 0800 to 1630 BST.
- A £100 million buyback window started July 1 and will run through July 21. The previous £200 million tranche finished on June 26.
- At current prices, the fresh tranche is about 4.2 million shares, equal to 0.24% of voting rights as of June 30.
- Goldman Sachs bumped its RELX price target to 3,100p from 3,000p and kept its Buy call before the July 23 results.
RELX PLC (LON:REL) ticked up 0.38% to 2,375p in London Wednesday. The increase left the stock well off its peak. Shares opened at 2,376p, hit a session high of 2,392p, and dropped to 2,259p at the low. Volume came in at 3.15 million, below the 5.10 million average.
The key issue for investors is the price RELX pays for its own stock. The company kicked off a £100 million irrevocable buyback on July 1, running through July 21. That comes after it wrapped up a £200 million buyback on June 26. Both pieces fit into the company’s bigger £2.25 billion plan to 2026, first laid out in February, with all shares bought going into treasury.
The tape still shows losses over the past year, despite Wednesday’s gain. The table uses the 16:02 London price and numbers from the June 30 LSE/FTSE Russell technicals.
| RELX measure | Latest data |
|---|---|
| London price at 16:02 BST | 2,375p |
| Day move | up 0.38% |
| Intraday range | traded between 2,259p and 2,392p |
| Volume vs average | 3.15 million shares versus usual 5.10 million |
| 52-week high / low | high 4,030p, low 1,991p |
| YTD move to June 30 | down 21.7% |
| 52-week move to June 30 | off 39.7% |
| Price vs 50-day average | 5.7% under |
| Price vs 200-day average | 16.1% under |
The gap matters for repurchase calculations. At 2,375p, £100 million gets about 4.21 million shares, not counting fees or price moves. RELX’s voting-rights notice from July 1 said the count was 1.755 billion on June 30, so this July round would be nearly 0.24% of that. But at the 52-week high of 4,030p, the same £100 million only gets roughly 2.48 million shares.
| Buyback item | Stated amount or share count | Implied at 2,375p |
|---|---|---|
| Latest July 1–21 buyback | £100 mln | 4.21 mln shares |
| New buyback as % of June 30 voting rights | — | 0.24% |
| Total 2026 buyback programme | £2.25 bln | 94.74 mln shares |
| Total plan as % of June 30 voting rights | — | 5.40% |
| Shares already repurchased since Jan. 2 | 69.19 mln | 3.94% of current voting rights |
| £100 mln at last year’s high of 4,030p | — | 2.48 mln shares |
RELX has been active in the market, buying 3,006,192 shares between June 22 and June 26 via ABN AMRO Bank N.V. AMS:ABN. The volume-weighted average prices each day ranged from 2,326.1085p up to 2,366.2929p. RELX has now bought 69,187,466 shares since Jan. 2.
RELX updated its share count, reporting 1.828 billion ordinary shares in issue as of June 30, with 73.3 million in treasury. That leaves 1.755 billion voting rights outstanding.
Goldman Sachs analyst Adam Berlin lifted his price target to 3,100p from 3,000p on the stock and stuck with a Buy. Berlin sees a solid half-year, though he flagged weakness in exhibitions as the Middle East war weighs on that part of the business, the July 1 broker note summary said.
The main debate for the stock still centers on Berlin’s earlier AI call. Back in June, he said RELX shouldn’t be in the AI “at risk” group, arguing it has a strong moat. He saw AI products driving sales growth up toward 8%. TipRanks
RELX told investors in its April update that Legal is posting double-digit gains in law firms and corporate legal. The company credited Lexis+ with Protégé, its AI-powered research and analytics tool. It pointed to AI adoption in STM, too, and stuck to its full-year forecast that underlying adjusted operating profit will grow faster than revenue.
RELX is set to report results for the six months ended June 30 on July 23. Until then, ABN AMRO can keep buying in July as long as the buyback rules allow and the stock stays under both its 50-day and 200-day averages.